Publication | Closed Access

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

Hematological MalignancyHealth SciencesMedicineHematologyPharmacologyPharmacotherapyRadiation OncologyOncologyClinical EfficacyConventional DosageLow-dose Arsenic Trioxide